These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 24015262)
41. Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic filariasis. Dakshinamoorthy G; Samykutty AK; Munirathinam G; Shinde GB; Nutman T; Reddy MV; Kalyanasundaram R PLoS One; 2012; 7(4):e34077. PubMed ID: 22496777 [TBL] [Abstract][Full Text] [Related]
42. Immunization with Yadav S; Sharma P; Sharma A; Ganga L; Saxena JK; Srivastava M ACS Infect Dis; 2021 Apr; 7(4):790-799. PubMed ID: 33667079 [TBL] [Abstract][Full Text] [Related]
43. Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection. Arumugam S; Wei J; Liu Z; Abraham D; Bell A; Bottazzi ME; Hotez PJ; Zhan B; Lustigman S; Klei TR PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004586. PubMed ID: 27045170 [TBL] [Abstract][Full Text] [Related]
44. Ligand binding properties of two Brugia malayi fatty acid and retinol (FAR) binding proteins and their vaccine efficacies against challenge infection in gerbils. Zhan B; Arumugam S; Kennedy MW; Tricoche N; Lian LY; Asojo OA; Bennuru S; Bottazzi ME; Hotez PJ; Lustigman S; Klei TR PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006772. PubMed ID: 30296268 [TBL] [Abstract][Full Text] [Related]
45. Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation. Dakshinamoorthy G; Kalyanasundaram R Vaccine; 2013 Dec; 32(1):19-25. PubMed ID: 24211167 [TBL] [Abstract][Full Text] [Related]
46. Inflammatory mediator release by Brugia malayi from macrophages of susceptible host Mastomys coucha and THP-1 and RAW 264.7 cell lines. Verma SK; Kushwaha V; Dubey V; Saxena K; Sharma A; Murthy PK Asian Pac J Trop Med; 2011 Feb; 4(2):92-6. PubMed ID: 21771428 [TBL] [Abstract][Full Text] [Related]
47. Brugia pahangi: immunization with early L3 ES alters parasite migration, and reduces microfilaremia and lymphatic lesion formation in gerbils (Meriones unguiculatus). Zipperer GR; Arumugam S; Chirgwin SR; Coleman SU; Shakya KP; Klei TR Exp Parasitol; 2013 Oct; 135(2):446-55. PubMed ID: 23981910 [TBL] [Abstract][Full Text] [Related]
48. The serpin secreted by Brugia malayi microfilariae, Bm-SPN-2, elicits strong, but short-lived, immune responses in mice and humans. Zang X; Atmadja AK; Gray P; Allen JE; Gray CA; Lawrence RA; Yazdanbakhsh M; Maizels RM J Immunol; 2000 Nov; 165(9):5161-9. PubMed ID: 11046048 [TBL] [Abstract][Full Text] [Related]
49. Effect of chemotherapeutic treatment on cytokine (IFN-gamma, IL-2, IL-4, IL-5, IL-10) gene transcription in response to specific antigens in Brugia malayi-infected Mastomys coucha. Saunders M; Taubert A; Dafa'alla T; Zahner H Parasitol Res; 2008 Oct; 103(5):1163-76. PubMed ID: 18679719 [TBL] [Abstract][Full Text] [Related]
51. Immunogenicity and protective efficacy of Recombinase A from Wolbachia endosymbiont of filarial nematode Brugia malayi (wBmRecA). Gangwar M; Jha R; Goyal M; Srivastava M Vaccine; 2019 Jan; 37(4):571-580. PubMed ID: 30595344 [TBL] [Abstract][Full Text] [Related]
52. Protective immune responses to biolistic DNA vaccination of Brugia malayi abundant larval transcript-2. Joseph SK; Sambanthamoorthy S; Dakshinamoorthy G; Munirathinam G; Ramaswamy K Vaccine; 2012 Oct; 30(45):6477-82. PubMed ID: 22885273 [TBL] [Abstract][Full Text] [Related]
53. A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds. Anand SB; Kodumudi KN; Reddy MV; Kaliraj P J Helminthol; 2011 Dec; 85(4):442-52. PubMed ID: 21208482 [TBL] [Abstract][Full Text] [Related]
54. Epitope mapping of Brugia malayi ALT-2 and the development of a multi-epitope vaccine for lymphatic filariasis. Madhumathi J; Prince PR; Rao DN; Karande AA; Reddy MV; Kaliraj P J Helminthol; 2017 Jan; 91(1):43-54. PubMed ID: 26892175 [TBL] [Abstract][Full Text] [Related]
55. Immune Response to Hameed A; Natarajan M; Jabbar S; Dhanasekaran JJ; Kumar K; Sivanesan S; Kron M; Dhanasekaran A Lymphat Res Biol; 2019 Aug; 17(4):447-456. PubMed ID: 30570354 [No Abstract] [Full Text] [Related]
56. Evaluation of immune response elicited by inulin as an adjuvant with filarial antigens in mice model. Mahalakshmi N; Aparnaa R; Kaliraj P Scand J Immunol; 2014 Oct; 80(4):261-70. PubMed ID: 25041426 [TBL] [Abstract][Full Text] [Related]
57. Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi. Verma SK; Bansal I; Vedi S; Saxena JK; Katoch VM; Bhattacharya SM Parasitol Res; 2008 Feb; 102(3):481-9. PubMed ID: 18064491 [TBL] [Abstract][Full Text] [Related]
58. Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis. Joseph SK; Ramaswamy K Vaccine; 2013 Jul; 31(33):3320-6. PubMed ID: 23735679 [TBL] [Abstract][Full Text] [Related]
59. Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis. Anugraha G; Jeyaprita PJ; Madhumathi J; Sheeba T; Kaliraj P Acta Parasitol; 2013 Dec; 58(4):468-77. PubMed ID: 24338307 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis. Veerapathran A; Dakshinamoorthy G; Gnanasekar M; Reddy MV; Kalyanasundaram R PLoS Negl Trop Dis; 2009 Jun; 3(6):e457. PubMed ID: 19513102 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]